Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Med Genet B Neuropsychiatr Genet ; 174(3): 295-314, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28139055

ABSTRACT

22q11.2 deletion syndrome is a neurogenetic disorder resulting in the deletion of over 40 genes. Up to 40% of individuals with 22q11.2DS develop schizophrenia, though little is known about the underlying mechanisms. We hypothesized that allelic variation in functional polymorphisms in seven genes unique to the deleted region would affect lobar brain volumes, which would predict risk for psychosis in youth with 22q11.2DS. Participants included 56 individuals (30 males) with 22q11.2DS. Anatomic MR images were collected and processed using Freesurfer. Participants were genotyped for 10 SNPs in the COMT, DGCR8, GNB1L, PIK4CA, PRODH, RTN4R, and ZDHHC8 genes. All subjects were assessed for ultra high risk symptoms of psychosis. Allelic variation of the rs701428 SNP of RTN4R was significantly associated with volumetric differences in gray matter of the lingual gyrus and cuneus of the occipital lobe. Moreover, occipital gray matter volumes were robustly associated with ultra high risk symptoms of psychosis in the presence of the G allele of rs701428. Our results suggest that RTN4R, a relatively under-studied gene at the 22q11 locus, constitutes a susceptibility gene for psychosis in individuals with this syndrome through its alteration of the architecture of the brain. © 2017 Wiley Periodicals, Inc.


Subject(s)
Abnormalities, Multiple/genetics , Abnormalities, Multiple/psychology , DiGeorge Syndrome/genetics , DiGeorge Syndrome/psychology , Nogo Receptor 1/genetics , Psychotic Disorders/genetics , Adolescent , Alleles , Catechol O-Methyltransferase/genetics , Chromosome Deletion , Chromosomes, Human, Pair 22/genetics , Female , Genetic Association Studies , Genetic Predisposition to Disease , Genotype , Gray Matter , Humans , Magnetic Resonance Imaging , Male , Neuroanatomy , Neurodevelopmental Disorders/genetics , Nogo Receptor 1/physiology , Occipital Lobe , Polymorphism, Single Nucleotide/genetics , Psychiatric Status Rating Scales , Psychotic Disorders/etiology , Psychotic Disorders/psychology , Risk Factors , Schizophrenia/genetics , Young Adult
2.
J Neurosci ; 34(36): 11884-96, 2014 09 03.
Article in English | MEDLINE | ID: mdl-25186737

ABSTRACT

Several studies have elucidated the significance of a disintegrin and metalloproteinase proteins (ADAMs) in PNS myelination, but there is no evidence if they also play a role in oligodendrogenesis and CNS myelination. Our study identifies ADAM17, also called tumor necrosis factor-α converting enzyme (TACE), as a novel key modulator of oligodendrocyte (OL) development and CNS myelination. Genetic deletion of TACE in oligodendrocyte progenitor cells (OPs) induces premature cell cycle exit and reduces OL cell survival during postnatal myelination of the subcortical white matter (SCWM). These cellular and molecular changes lead to deficits in SCWM myelination and motor behavior. Mechanistically, TACE regulates oligodendrogenesis by modulating the shedding of EGFR ligands TGFα and HB-EGF and, consequently, EGFR signaling activation in OL lineage cells. Constitutive TACE depletion in OPs in vivo leads to similar alterations in CNS myelination and motor behavior as to what is observed in the EGFR hypofunctional mouse line EgfrWa2. EGFR overexpression in TACE-deficient OPs restores OL survival and development. Our study reveals an essential function of TACE in oligodendrogenesis, and demonstrates how this molecule modulates EGFR signaling activation to regulate postnatal CNS myelination.


Subject(s)
ADAM Proteins/metabolism , Brain/metabolism , Myelin Sheath/metabolism , Neurogenesis , Oligodendroglia/metabolism , ADAM Proteins/genetics , ADAM17 Protein , Animals , Brain/growth & development , Brain/physiology , Cell Line , Cell Lineage , Cells, Cultured , ErbB Receptors/genetics , ErbB Receptors/metabolism , Heparin-binding EGF-like Growth Factor , Intercellular Signaling Peptides and Proteins/metabolism , Locomotion , Mice , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Oligodendroglia/cytology , Transforming Growth Factor alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...